Stockpolly
Search
TIL · NASDAQ · Biotechnology

Instil Bio (TIL)

Biotechnology developer seeking therapeutic candidates through acquisitions and in-licensing.

$7.78
At close+0.09 (+1.17%)
Watchlist

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Cost of revenue011001000000
Gross profit0−1−100−1000000
6712191424113123151066
Research & development827311579310
121011111110966655
Selling & marketing00−1000000000
General & administrative1201211110966655
Other expenses4600112016110000
Operating income−67−13−20−14−24−11−31−23−15−10−6−6
−10−5−110221121
Interest income222221111111
Interest expense222223122122
Other non-operating income−1−23−1−3−2−3−4−3−2−32
Income before tax−67−13−24−15−23−12−28−21−14−8−4−4
Net income from continuing operations−67−13−24−15−23−12−28−21−14−8−4−4
Net income−67−13−24−15−23−12−28−21−14−8−4−4
EPS, basic−$10.37−$1.99−$3.74−$2.29−$3.54−$1.82−$4.32−$3.24−$2.01−$1.21−$0.62−$0.63
EPS, diluted−$10.37−$1.99−$3.74−$2.29−$3.54−$1.82−$4.32−$3.24−$2.01−$1.21−$0.62−$0.63
Weighted average shares, basic777777777777
Weighted average shares, diluted777777777777
EBITDA−64−10−22−12−20−9−27−20−12−7−3−8
Depreciation & amortization111111000000
EBIT−65−11−23−13−21−9−27−20−12−7−3−8